A staff member works at the COVID-19 vaccine production plant of Sinovac Biotech in Beijing on Sept 24. (Photo/CHINA DAILY)

A total of 184 countries and economies have now joined COVAX, an international initiative co-led by the World Health Organization (WHO) and partners to ensure effective and equitable global access to COVID-19 vaccines, WHO Director-General Tedros Adhanom Ghebreyesus announced on Monday.

10月19日，世界卫生组织总干事谭德塞宣布，全球已有184个国家和经济体加入“新冠肺炎疫苗实施计划”（COVAX），这是一项由世界卫生组织和其合作伙伴共同主导的一项国际计划，以确保全球有效及公平地获得新冠疫苗。

As one of the leading countries in vaccine development, China has officially joined COVAX (COVID-19 Vaccines Global Access). This is an important step China has taken to uphold the concept of a shared community of health for all and to honor its commitment of turning COVID-19 vaccines into a global public good.

作为疫苗研发的主要国家之一，中国已经正式加入“新冠肺炎疫苗实施计划”（COVAX）。这是中国秉持人类卫生健康共同体理念、履行自身承诺推动疫苗成为全球公共产品的一个重要举措。

According to the website of WHO, as of Oct. 19, there were 198 COVID-19 candidate vaccines being developed worldwide, and 44 of them were in clinical trials.

世界卫生组织网站显示，截至10月19日，全球正在研发的候选新冠疫苗共有198种，其中有44种已进入临床试验阶段。

Collected and edited by Lv Yun

Source: Xinhua, China Daily

_{扫描以下二维码，定格“Buzzword”专题，学习更多英语热词吧！}